187 related articles for article (PubMed ID: 6696460)
21. [Histological and histochemical changes in ovarian mucinous tumors. A study of 112 cases].
Zhu YG
Zhonghua Bing Li Xue Za Zhi; 1987 Dec; 16(4):272-4, 56. PubMed ID: 2968163
[No Abstract] [Full Text] [Related]
22. [Ganglioside content and profile in the ovarian tumor tissues and in the biological body fluids of patients].
Novikov AM; Makhova EE; Travnikov ME; Bassalyk LS
Eksp Onkol; 1989; 11(3):52-5. PubMed ID: 2752944
[TBL] [Abstract][Full Text] [Related]
23. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
25. Investigation of Vicia graminea lectin- and Vicia unijuga lectin-binding glycoproteins as novel oncofetal antigens in cyst and ascitic fluids of human ovarian tumors in benign, dysplastic, and malignant stages.
Ohyama K; Yanagi K; Hayashi S; Matsuda T; Suzuki R; Ohkuma S; Watanabe H; Hirakawa S; Yamakawa T
Cancer Detect Prev; 1997; 21(4):304-11. PubMed ID: 9232320
[TBL] [Abstract][Full Text] [Related]
26. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
[TBL] [Abstract][Full Text] [Related]
27. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
Sun ZC
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
[TBL] [Abstract][Full Text] [Related]
28. [Giant benign and malignant pathology of the ovary].
Docimo L; Pellegrini C; Docimo G; Pacifico F; Di Muria A
Minerva Chir; 1992 Oct; 47(20):1661-4. PubMed ID: 1480297
[TBL] [Abstract][Full Text] [Related]
29. Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.
Aguirre P; Scully RE; Dayal Y; DeLellis RA
Am J Surg Pathol; 1984 May; 8(5):345-56. PubMed ID: 6203413
[TBL] [Abstract][Full Text] [Related]
30. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
31. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
Prayson RA; Hart WR; Petras RE
Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
[TBL] [Abstract][Full Text] [Related]
32. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
33. Ovarian adenosarcoma arising from benign cystadenoma and associated intraoperative consultation pitfalls.
Chen ZW; Saad RS
Int J Gynecol Pathol; 2010 Sep; 29(5):415-8. PubMed ID: 20736764
[TBL] [Abstract][Full Text] [Related]
34. Tumor markers of epithelial ovarian neoplasms.
Khalifa MA; Sesterhenn IA
Int J Gynecol Pathol; 1990; 9(3):217-30. PubMed ID: 2197239
[TBL] [Abstract][Full Text] [Related]
35. Management of massive ovarian tumors.
Pretorius RG; Matory WE; LaFontaine D
Surg Gynecol Obstet; 1989 Dec; 169(6):532-6. PubMed ID: 2554517
[TBL] [Abstract][Full Text] [Related]
36. HLA-G is a potential tumor marker in malignant ascites.
Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
[TBL] [Abstract][Full Text] [Related]
37. Expression of alpha-smooth muscle actin in benign or malignant ovarian tumors.
Kobayashi H; Tsuruchi N; Sugihara K; Kaku T; Saito T; Kamura T; Tsukamoto N; Nakano H; Taniguchi S
Gynecol Oncol; 1993 Mar; 48(3):308-13. PubMed ID: 8462899
[TBL] [Abstract][Full Text] [Related]
38. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
39. [Gynecological cancer and ferritin--a study on the carcinofetoplacental ferritin].
Kobayashi H; Sakura H; Mizutani S
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):47-52. PubMed ID: 6827163
[TBL] [Abstract][Full Text] [Related]
40. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
